/

NSPR

InspireMD Inc.Closed

0.5000+0.01 +1.71%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delay

Open

0.5423

Prev close

0.4916

Day range

0.48070.5738

52-week range

0.46002.54

Volume

96.63K1.17×

Mkt cap

23.24M

P/E ttm

—

Fwd P/E

-1.03

EPS ttm

-0.6200

Div yield

0.00%

Earnings

Aug 17, 2026

From 52w high

−80.31%

Price Chart

Yahoo Finance · delayed

NSPROct 13, 2026O 0.5400H 0.5700L 0.4800C 0.5000+0.0100 (+2.04%)Vol 96.60K

SMA 500.7616
SMA 2001.1570

1Y change −79.34% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

NSPR InspireMD Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −5.66%
1 month: −36.71%
3 months: −30.56%
6 months: −62.96%
Year to date: −71.91%
1 year: −79.34%

Valuation & ownership

Market cap: 23.24M
Enterprise value: −4.15M
P/E (ttm): —
Forward P/E: -1.03
PEG ratio: —
Price / book: 0.74
Price / sales (ttm): 2.14
EV / EBITDA: 0.08
EPS (ttm): -0.6200
EPS (forward): -0.4833
Beta (5y monthly): 0.83
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 46.49M
Float: 28.72M
Short % of float: 0.05%
Short ratio (days): 0.39
Held by insiders: 19.98%
Held by institutions: 46.31%
Avg volume (3m): 82.73K
50-day average: 0.7652
200-day average: 1.16
52-week change: −79.34%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): oversold 25.6
vs 50-day SMA: −34.35%
vs 200-day SMA: −56.79%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 14.45%
Realised vol (20d, ann.): 65.1%
From 52-week high: −80.31%
From 52-week low: +8.70%

ANR

Analyst Consensus

3 analysts

Consensus

—

Mean target

3.33

+566.67% implied

Low 3.00Median 3.00High 4.00

Recommendation trend

Now3 / 0 / 0
1m ago3 / 0 / 0

Buy / hold / sell counts

DES

About InspireMD Inc.

Yahoo Finance profile

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Sector: Healthcare
Industry: Medical Devices
Employees: 127
Headquarters: Miami, FL, United States
Website: inspiremd.com
Officers: Mr. Marvin L. Slosman President, CEO & Director
Mr. Michael A. Lawless CFO, Secretary & Treasurer
Mr. Vince Turturro Senior Vice President of Global Operations & Engineering
Ms. Kathleen Kennedy Senior Vice President of Global Sales & Marketing

SEAS

Seasonality · NSPR

2011–2026 · monthly returns

Strongest month Jan +11.13%Weakest month Mar −17.27%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-11.2	12.7	-8.4	-27.6	-22.0	-23.9	-7.1	36.9	-24.7	-25.4			−71.9%
2025	-1.9	24.8	-16.5	-5.6	0.8	-11.3	22.9	-12.5	-1.2	-8.3	-10.4	-10.1	−32.3%
2024	0.7	-2.8	-13.8	-18.1	41.8	-9.1	15.2	-4.5	-2.5	-7.5	18.5	-10.5	−6.4%
2023	37.2	-2.5	-1.7	-8.0	76.9	36.4	32.7	6.0	-7.4	3.7	-31.9	21.6	+226.7%
2022	-10.6	-1.1	19.9	-25.0	-6.7	-10.7	-12.0	2.8	-18.2	-23.6	9.7	-30.6	−71.5%
2021	102.9	24.6	-22.1	-40.1	-11.1	-5.6	-25.5	20.7	-9.7	-3.4	-7.6	-17.5	−40.8%
2020	4.6	-21.2	-30.3	22.6	10.5	-44.0	-2.1	-15.2	-17.9	9.4	2.9	-5.6	−68.5%
2019	12.5	-5.6	-17.6	-34.0	-23.4	-3.7	-2.9	-35.6	-39.0	-13.1	-10.6	6.9	−86.5%
2018	76.9	-70.4	-56.3	17.3	-2.5	-79.0	-16.0	-9.5	15.8	9.1	-12.5	-23.8	−96.5%
2017	-10.8	7.6	-58.8	-33.3	-21.2	28.8	-31.3	-28.3	21.2	2.5	-65.9	-7.1	−94.8%
2016	-36.4	-25.0	21.4	-3.9	-6.1	-30.4	-43.8	-16.7	-46.7	-28.5	102.8	-13.8	−88.6%
2015	2.6	-25.0	-46.7	-18.8	-11.5	21.7	-25.0	-9.5	-10.5	-40.6	-10.9	-2.2	−88.7%
2014	20.7	5.4	-2.6	-31.1	19.0	18.0	-22.4	3.5	-7.2	-22.7	-42.9	-19.6	−68.3%
2013	-11.5	-21.7	-6.7	4.0	-12.2	-3.9	9.5	-11.2	8.4	21.0	0.7	-13.4	−36.9%
2012	-31.2	33.3	-10.0	-38.9	-29.1	35.9	8.5	41.7	39.3	-40.5	-15.6	-14.5	−55.3%
2011					62.3	-12.3	-7.6	-16.1	14.0	-15.9	21.6	-3.1	+24.6%

INSD

Insider Activity · NSPR

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

394.4K shares

Sells, 6 months

85.3K shares

Net shares

+309.1K

Net change in insider shares

+3.40%

Date	Insider	Transaction	Shares	Value
May 26, 2026	Stuka PaulDirector	Purchase at price 0.88 per share.	20K	$17.50K
May 18, 2026	Gleason Shane ThomasOfficer	Sale at price 1.01 - 3.65 per share.	85.3K	$189.59K
May 13, 2026	Stuka PaulDirector	Purchase at price 1.15 - 1.16 per share.	15K	$17.32K
May 11, 2026	Slosman MarvinChief Executive Officer	Purchase at price 1.20 per share.	21K	$25.20K
May 10, 2026	Stuka PaulDirector	Purchase at price 1.16 - 1.19 per share.	75.6K	$88.03K
May 10, 2026	Stuka PaulDirector	Purchase at price 1.16 - 1.19 per share.	75.6K	$88.03K
May 6, 2026	Roubin Gary SDirector	Purchase at price 1.18 per share.	90K	$106.20K
May 6, 2026	Ward Scott RaymondDirector	Purchase at price 1.15 per share.	89.3K	$102.64K
May 6, 2026	Stuka PaulDirector	Purchase at price 1.12 - 1.15 per share.	7.9K	$9.03K
Feb 1, 2026	Gleason Shane ThomasOfficer	Sale at price 1.57 - 1.66 per share.	61.2K	$99.33K
Jan 13, 2026	Berman MichaelDirector	Stock Award(Grant) at price 0.00 per share.	88.1K	—
Jan 13, 2026	Cohen Raymond WDirector	Stock Award(Grant) at price 0.00 per share.	44K	—
Jan 13, 2026	Slosman MarvinChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	1.11M	—
Jan 13, 2026	Roubin Gary SDirector	Stock Award(Grant) at price 0.00 per share.	88.1K	—
Jan 13, 2026	Ward Scott RaymondDirector	Stock Award(Grant) at price 0.00 per share.	88.1K	—
Jan 13, 2026	Stuka PaulDirector	Stock Award(Grant) at price 0.00 per share.	132.1K	—
Jan 13, 2026	Dearen Danny LDirector	Stock Award(Grant) at price 0.00 per share.	44K	—
Jan 13, 2026	Lawless Michael A.Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	226.7K	—
Jan 13, 2026	Gleason Shane ThomasOfficer	Stock Award(Grant) at price 0.00 per share.	453.4K	—
Jan 13, 2026	Tommasoli AndreaChief Operating Officer	Stock Award(Grant) at price 0.00 per share.	226.7K	—

13F

Investors Holding NSPR

latest 13F filings of 29 followed managers

Investors holding NSPR
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$79.0K	0.00%	112.83K	+541%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

NSPR

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

NSPR

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About InspireMD Inc.

Seasonality · NSPR

Insider Activity · NSPR

Congress Trades · NSPR

Investors Holding NSPR

Investors Holding NSPR

Congress Trades · NSPR

Insider Activity · NSPR

Seasonality · NSPR

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About InspireMD Inc.

Financial Snapshot

Earnings & Dividends

News